Health and financial analysis reinforces NIH’s decision to fund Women’s Health Initiative
National Institutes of Health (NIH): May 5, 2014
An in-depth analysis of final data from one of the Women’s Health Initiative (WHI) Postmenopausal Hormone Therapy Trials has found that the investment in WHI resulted in a return of $140 in net economic value for each dollar invested in the trial.
The WHI, sponsored by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI), has followed women in the study since 1993. Results of the trial of estrogen plus progestin were published in 2002. A paper examining the national post-study long-term financial and health outcomes of the WHI was published today in the Annals of Internal Medicine.
“I’m delighted to see these results from the WHI Postmenopausal Hormone Therapy Trial,” said NIH Director Francis S. Collins, M.D., Ph.D. “Americans should be pleased to see that their investment in NIH continues to provide such a strong return to their health and the economy.” Read More